Neurotrope Completes Licensing Agreement for Accelerated Synthesis of Alzheimer’s Drug Bryostatin-1 – Yahoo Finance

January 30, 2017 by  
Filed under Alzheimers News

Sponsored By
Neurotrope Completes Licensing Agreement for Accelerated Synthesis of Alzheimer's Drug Bryostatin-1
Yahoo Finance
30, 2017 /PRNewswire/ — Neurotrope, Inc. (NTRPD), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including Alzheimer's disease, announced today that it has signed a licensing agreement with …

and more »

More Info: Click here

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!

*